These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 35886861)

  • 1. Effects of the Lipid Profile, Type 2 Diabetes and Medication on the Metabolic Syndrome-Associated Gut Microbiome.
    Gradisteanu Pircalabioru G; Liaw J; Gundogdu O; Corcionivoschi N; Ilie I; Oprea L; Musat M; Chifiriuc MC
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
    Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
    Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome, Mycobiome and Related Metabolites Alterations in Patients with Metabolic Syndrome-A Pilot Study.
    Gradisteanu Pircalabioru G; Ilie I; Oprea L; Picu A; Petcu LM; Burlibasa L; Chifiriuc MC; Musat M
    Metabolites; 2022 Feb; 12(3):. PubMed ID: 35323661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the Gut Microbiota in Pregnant Women with Pregestational Type 2 Diabetes Mellitus.
    Ren Y; Hao L; Liu J; Wang P; Ding Q; Chen C; Song Y
    mSystems; 2023 Apr; 8(2):e0114622. PubMed ID: 36853013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
    Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
    Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects.
    Carrizales-Sánchez AK; Tamez-Rivera O; Rodríguez-Gutiérrez NA; Elizondo-Montemayor L; Gradilla-Hernández MS; García-Rivas G; Pacheco A; Senés-Guerrero C
    BMC Pediatr; 2023 May; 23(1):210. PubMed ID: 37138212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral metformin on gut microbiota characteristics and metabolite fractions in normal-weight type 2 diabetic mellitus patients.
    Niu X; Wang Y; Huang L; Guo P; Zhang S; Sun Y; Jin M
    Front Endocrinol (Lausanne); 2024; 15():1397034. PubMed ID: 39257903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Region-Specific Effects of Metformin on Gut Microbiome and Metabolome in High-Fat Diet-Induced Type 2 Diabetes Mouse Model.
    Cheng M; Jia X; Ren L; Chen S; Wang W; Wang J; Cong B
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
    Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
    mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis.
    Song H; Yoo Y; Hwang J; Na YC; Kim HS
    J Allergy Clin Immunol; 2016 Mar; 137(3):852-60. PubMed ID: 26431583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D, Gut Microbiota, and Cardiometabolic Diseases-A Possible Three-Way Axis.
    Sukik A; Alalwani J; Ganji V
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes.
    Zhao X; Zhang Y; Guo R; Yu W; Zhang F; Wu F; Shang J
    J Diabetes Res; 2020; 2020():8842651. PubMed ID: 33224990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children.
    Gallardo-Becerra L; Cornejo-Granados F; García-López R; Valdez-Lara A; Bikel S; Canizales-Quinteros S; López-Contreras BE; Mendoza-Vargas A; Nielsen H; Ochoa-Leyva A
    Microb Cell Fact; 2020 Mar; 19(1):61. PubMed ID: 32143621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection alters the gut microbiome in diabetes patients: A cross-sectional study from Bangladesh.
    Mannan A; Hoque MN; Noyon SH; Mehedi HMH; Foysal MJ; Salauddin A; Islam SMR; Sharmen F; Tanni AA; Siddiki AZ; Tay A; Siddique MM; Rahman MS; Galib SM; Akter F
    J Med Virol; 2023 Apr; 95(4):e28691. PubMed ID: 36946508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
    Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
    mBio; 2018 May; 9(3):. PubMed ID: 29789365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition.
    Koopen AM; de Clercq NC; Warmbrunn MV; Herrema H; Davids M; de Groot PF; Kootte RS; Bouter KEC; Nieuwdorp M; Groen AK; Prodan A
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32752028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
    Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could dysbiosis of inflammatory and anti-inflammatory gut bacteria have an implications in the development of type 2 diabetes? A pilot investigation.
    Kulkarni P; Devkumar P; Chattopadhyay I
    BMC Res Notes; 2021 Feb; 14(1):52. PubMed ID: 33549142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.